Home » Health Care

Vaccines and Biodefense

Biotechnology, Public Health, and National Security

How the industry can develop biodefense products.

Preparedness for Pandemics and Biodefense

In the wake of the September 11 terrorist attacks, BIO surveyed the industry and found that many biotech companies were already working on defense projects or developing technologies useful for both conventional health care and for defense against biological, chemical and radiological/nuclear agents.

Statement on Ethical Use of Biotechnology: To Promote Public Health and National Security and to Fight Against Bioterrorism

To Promote Public Health and National Security and to Fight Against Bioterrorism

Letters, Testimony & Comments

Pandemic and All-Hazards Preparedness Reauthorization Act
December 18 2012
Dear Speaker Boehner and Minority Leader Pelosi: On behalf of the Biotechnology Industry Organization (BIO), I am writing with our...
BIO Submits PAHPA Reauthorization Support Letter
November 16 2012
  Dear Chairmen Harkin, Upton and Pitts, Ranking Members Enzi and Waxman, Senators Burr and Casey, and Rep. Rogers:   On...
BIO Comments on IOM Report - Ranking Vaccines: A Prioritization Framework
June 15 2012
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Institute of Medicine’s (IOM...
BIO Comments on IOM Report - Ranking Vaccines: A Prioritization Framework
June 15 2012
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Institute of Medicine’s (IOM...
BIO Comments on CMS Electronic Health Record Incentive Program
May 17 2012
  The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare and Medicaid...
More Letters, Testimony & Comments →

Press Releases

BIO Praises The House of Representatives for Approving H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act
January 25 2013
The Biotechnology Industry Organization lauds the House of Representatives for passing H.R. 307, the Pandemic and All...
BIO Hails Senate Passage of PAHPA Reauthorization
March 8 2012
Washington, DC (March 8, 2012) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood...
BIO Strongly Supports Reauthorization of PAHPA and BioShield Special Reserve Fund
November 15 2011
Reauthorization demonstrates government commitment to national security priority Washington, D.C. (November 15,...
Leaders in Government, Biotechnology and Global Health Examine Innovative Ways to Accelerate Development of New Tools for Global Health
June 15 2011
WASHINGTON, D.C. (Wednesday, June 15, 2011) - High-level members of the Obama Administration will gather with leaders...
Congressman Price Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
More Press Releases →